A new lignan from Laggera crispata (Vahl) Hepper & J. R. I. Wood

Area of Science:

• Phytochemistry
• Natural Products Chemistry
• Pharmacology

Background:

• Laggera crispata is a plant species known for its potential medicinal properties.
• Natural products are a rich source of novel bioactive compounds.
• Isolation and characterization of plant-derived compounds are crucial for drug discovery.

Purpose of the Study:

• To isolate and identify chemical constituents from the petroleum ether fraction of Laggera crispata.
• To evaluate the biological activities of the isolated compounds, specifically antimicrobial and anticancer effects.

Main Methods:

• Phytochemical investigation involving solvent extraction and chromatographic separation techniques.
• Structural elucidation of isolated compounds using comprehensive spectral analysis, including Nuclear Magnetic Resonance (NMR), Infrared (IR), Ultraviolet (UV), and Mass Spectrometry (MS).
• In vitro bioactivity screening assays to assess antimicrobial activity against Staphylococcus aureus and cytotoxicity against the HepG2 liver cancer cell line.

Main Results:

• A new lignan, 9'-O-angelyllariciresinol (compound 1), was identified along with 20 known compounds (compounds 2-21).
• Compound 5 demonstrated significant inhibitory activity against Staphylococcus aureus.
• Compound 2 exhibited significant inhibitory effects on the HepG2 liver cancer cell line.

Conclusions:

• Laggera crispata is a valuable source of bioactive natural products.
• The isolated lignan 9'-O-angelyllariciresinol and other compounds possess promising antimicrobial and anticancer properties.
• Further research into these compounds could lead to the development of new therapeutic agents.